Clinical Trials Logo

ER clinical trials

View clinical trials related to ER.

Filter by:
  • None
  • Page 1

NCT ID: NCT02202746 Terminated - Breast Cancer Clinical Trials

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

Start date: September 9, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether lucitanib is safe and effective in the treatment of patients with FGF aberrant metastatic breast cancer, as well as in the treatment of patients with biomarker negative (FGF non-aberrant) metastatic breast cancer.